| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 29.04. | First-quarter sales strength buoys new GSK CEO Miels | ||
| 29.04. | UK study finds clue to rising cancer rates in younger people | ||
| 28.04. | Merck KGaA partners Remepy in PDURS-focused alliance | ||
| 28.04. | AI start-up Profluent nabs Lilly as first big pharma partner | ||
| 28.04. | Can Purdue finally get its bankruptcy plan over the line? | ||
| 28.04. | GSK eyes October FDA verdict on chronic hep B drug | ||
| 28.04. | Novartis shares fall as Entresto sales weaken | ||
| 28.04. | Boehringer/Zealand dual-acting drug causes 16.6% weight loss | ||
| 27.04. | Intellia files CRISPR drug after historic phase 3 readout | ||
| 27.04. | Lilly's M&A team strikes again with $2.3bn Ajax takeover | ||
| 27.04. | GSK/Tesaro claim denied in Jemperli lawsuit with AnaptysBio | ||
| 27.04. | Lilly falls on slower start for Foundayo versus Wegovy | ||
| 27.04. | New NIHR-funded TRC for Parkinson's disease | ||
| 27.04. | Sun sets out $11.75bn takeover play for Organon | ||
| 24.04. | FDA grants three priority vouchers to psychedelics | ||
| 24.04. | FDA declines to approve AbbVie's Botox follow-up | ||
| 24.04. | FDA clears first genetic hearing loss gene therapy | ||
| 23.04. | Trump's DOJ reschedules medicinal marijuana, increasing access | ||
| 23.04. | Ray's upscaled Series B, and other biofinancings | ||
| 23.04. | UK Biobank patient data placed on sale in China | ||
| 23.04. | Novo says oral semaglutide works in diabetic kids | ||
| 23.04. | UK Biobank patient data stolen and placed on sale in China | ||
| 23.04. | UK Biobank patient data hacked and placed on sale in China | ||
| 23.04. | Swiss franc strength puts Roche's results in a poor light | ||
| 23.04. | Sanofi welcomes incoming CEO with sales lift |